Chardonnet Laurent 4
4 · Prelude Therapeutics Inc · Filed Dec 22, 2022
Insider Transaction Report
Form 4
Chardonnet Laurent
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-12-21+75,000→ 75,000 totalExercise: $4.90Exp: 2032-12-20→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the total shares on December 21, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.